(VTR) Ventas - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US92276F1003

Senior Housing, Medical Buildings, Research Centers, Healthcare Facilities

VTR EPS (Earnings per Share)

EPS (Earnings per Share) of VTR over the last years for every Quarter: "2020-09-30": 0.03, "2020-12-31": 0.29, "2021-03-31": -0.15, "2021-06-30": 0.23, "2021-09-30": 0.16, "2021-12-31": -0.1, "2022-03-31": 0.1, "2022-06-30": -0.11, "2022-09-30": 0.0031, "2022-12-31": -0.11, "2023-03-31": 0.04, "2023-06-30": 0.18, "2023-09-30": -0.18, "2023-12-31": -0.23, "2024-03-31": -0.03, "2024-06-30": 0.05, "2024-09-30": 0.05, "2024-12-31": 0.13, "2025-03-31": 0.1, "2025-06-30": 0.15,

VTR Revenue

Revenue of VTR over the last years for every Quarter: 2020-09-30: 918.94, 2020-12-31: 921.165, 2021-03-31: 910.291, 2021-06-30: 919.194, 2021-09-30: 976.078, 2021-12-31: 1022.444, 2022-03-31: 1017.554, 2022-06-30: 1022.938, 2022-09-30: 1037.276, 2022-12-31: 1051.425, 2023-03-31: 1077.245, 2023-06-30: 1106.358, 2023-09-30: 1149.832, 2023-12-31: 1164.392, 2024-03-31: 1199.914, 2024-06-30: 1200.98, 2024-09-30: 1236.315, 2024-12-31: 1287.057, 2025-03-31: 1358.074, 2025-06-30: 1420.893,

Description: VTR Ventas

Ventas Inc (NYSE:VTR) is a prominent S&P500 real estate investment trust (REIT) specializing in healthcare and senior housing facilities. With a vast portfolio of approximately 1,400 properties across North America and the UK, the company plays a crucial role in supporting the growing aging population. The core of its business lies in its 850 senior housing communities, which provide essential services to residents, enabling them to live in supported environments.

The companys diversified portfolio also includes outpatient medical buildings, research centers, and healthcare facilities, contributing to its position in the longevity economy. Ventas leverages its operational expertise, data-driven insights from its proprietary Ventas OI platform, and extensive industry relationships to drive growth and deliver strong performance. Its seasoned team is committed to excellence, integrity, and enhancing the quality of life for its residents.

From a financial perspective, Ventas demonstrates a robust market presence with a market capitalization of approximately $29.24 billion. The companys dividend yield is an important metric for income-focused investors, and as a REIT, it is required to distribute a significant portion of its income to shareholders. The Funds From Operations (FFO) per share and the Adjusted Funds From Operations (AFFO) per share are key performance indicators for REITs like Ventas, providing insights into its operational cash flow generation capabilities.

In terms of valuation, the Price-to-Earnings (P/E) ratio of 190.50 and Forward P/E of 153.85 indicate the markets expectations for the companys future earnings growth. The Return on Equity (RoE) of 1.37% suggests that the company is currently not generating significant returns on shareholders equity, which may be a point of concern for investors. However, the companys financial position, operational expertise, and growth prospects in the senior housing and healthcare sectors are critical factors that investors should consider when evaluating Ventas investment potential.

Additional key metrics to monitor for Ventas include its occupancy rates, rental growth, and the performance of its various business segments. The companys ability to maintain high occupancy rates and grow its rental income will be crucial in driving its future financial performance. Moreover, its exposure to different markets and segments within the healthcare and senior housing sectors can provide insights into its diversification benefits and potential vulnerabilities.

VTR Stock Overview

Market Cap in USD 31,563m
Sub-Industry Health Care REITs
IPO / Inception 1998-05-04

VTR Stock Ratings

Growth Rating 67.0%
Fundamental 66.3%
Dividend Rating 46.5%
Return 12m vs S&P 500 -9.19%
Analyst Rating 4.45 of 5

VTR Dividends

Dividend Yield 12m 2.83%
Yield on Cost 5y 5.16%
Annual Growth 5y -3.43%
Payout Consistency 96.5%
Payout Ratio 4.3%

VTR Growth Ratios

Growth Correlation 3m 84.3%
Growth Correlation 12m 62.6%
Growth Correlation 5y 47.6%
CAGR 5y 18.35%
CAGR/Max DD 3y 0.80
CAGR/Mean DD 3y 2.65
Sharpe Ratio 12m 1.25
Alpha 0.00
Beta 0.968
Volatility 19.87%
Current Volume 2890.6k
Average Volume 20d 2459.7k
Stop Loss 65.3 (-3%)
Signal -0.83

Piotroski VR‑10 (Strict, 0-10) 2.0

Net Income (191.2m TTM) > 0 and > 6% of Revenue (6% = 318.1m TTM)
FCFTA 0.04 (>2.0%) and ΔFCFTA 0.50pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue -1.10% (prev -4.47%; Δ 3.37pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.06 (>3.0%) and CFO 1.52b > Net Income 191.2m (YES >=105%, WARN >=100%)
Net Debt (12.66b) to EBITDA (2.01b) ratio: 6.30 <= 3.0 (WARN <= 3.5)
Current Ratio 0.95 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (453.0m) change vs 12m ago 10.00% (target <= -2.0% for YES)
Gross Margin 36.23% (prev 11.68%; Δ 24.55pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 20.79% (prev 19.22%; Δ 1.57pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 1.31 (EBITDA TTM 2.01b / Interest Expense TTM 603.3m) >= 6 (WARN >= 3)

Altman Z'' -1.73

(A) -0.00 = (Total Current Assets 1.21b - Total Current Liabilities 1.27b) / Total Assets 26.47b
(B) -0.27 = Retained Earnings (Balance) -7.21b / Total Assets 26.47b
(C) 0.03 = EBIT TTM 790.4m / Avg Total Assets 25.50b
(D) -0.99 = Book Value of Equity -14.34b / Total Liabilities 14.55b
Total Rating: -1.73 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 66.25

1. Piotroski 2.0pt = -3.0
2. FCF Yield 2.44% = 1.22
3. FCF Margin 20.23% = 5.06
4. Debt/Equity 1.13 = 1.89
5. Debt/Ebitda 6.50 = -2.50
6. ROIC - WACC (= 3.13)% = 3.91
7. RoE 1.76% = 0.15
8. Rev. Trend 98.51% = 7.39
9. EPS Trend 42.68% = 2.13

What is the price of VTR shares?

As of September 19, 2025, the stock is trading at USD 67.34 with a total of 2,890,600 shares traded.
Over the past week, the price has changed by -2.76%, over one month by +0.19%, over three months by +8.12% and over the past year by +7.64%.

Is Ventas a good stock to buy?

Partly, yes. Based on ValueRay´s Fundamental Analyses, Ventas (NYSE:VTR) is currently (September 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 66.25 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of VTR is around 66.76 USD . This means that VTR is currently overvalued and has a potential downside of -0.86%.

Is VTR a buy, sell or hold?

Ventas has received a consensus analysts rating of 4.45. Therefore, it is recommended to buy VTR.
  • Strong Buy: 12
  • Buy: 5
  • Hold: 3
  • Sell: 0
  • Strong Sell: 0

What are the forecasts/targets for the VTR price?

Issuer Target Up/Down from current
Wallstreet Target Price 77.4 14.9%
Analysts Target Price 77.4 14.9%
ValueRay Target Price 75.2 11.6%

Last update: 2025-09-12 04:47

VTR Fundamental Data Overview

Market Cap USD = 31.56b (31.56b USD * 1.0 USD.USD)
CCE Cash And Equivalents = 614.2m USD (last quarter)
P/E Trailing = 161.5116
P/E Forward = 99.0099
P/S = 5.9831
P/B = 2.7376
P/EG = 1.7374
Beta = 0.889
Revenue TTM = 5.30b USD
EBIT TTM = 790.4m USD
EBITDA TTM = 2.01b USD
Long Term Debt = 13.06b USD (from longTermDebt, last quarter)
Short Term Debt = 1.37m USD (from shortTermDebt, last quarter)
Debt = 13.06b USD (Calculated: Short Term 1.37m + Long Term 13.06b)
Net Debt = 12.66b USD (from netDebt column, last quarter)
Enterprise Value = 44.01b USD (31.56b + Debt 13.06b - CCE 614.2m)
Interest Coverage Ratio = 1.31 (Ebit TTM 790.4m / Interest Expense TTM 603.3m)
FCF Yield = 2.44% (FCF TTM 1.07b / Enterprise Value 44.01b)
FCF Margin = 20.23% (FCF TTM 1.07b / Revenue TTM 5.30b)
Net Margin = 3.61% (Net Income TTM 191.2m / Revenue TTM 5.30b)
Gross Margin = 36.23% ((Revenue TTM 5.30b - Cost of Revenue TTM 3.38b) / Revenue TTM)
Tobins Q-Ratio = -3.07 (set to none) (Enterprise Value 44.01b / Book Value Of Equity -14.34b)
Interest Expense / Debt = 1.15% (Interest Expense 150.3m / Debt 13.06b)
Taxrate = -74.69% (set to none) (-37.8m / 50.6m)
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = 0.95 (Total Current Assets 1.21b / Total Current Liabilities 1.27b)
Debt / Equity = 1.13 (Debt 13.06b / last Quarter total Stockholder Equity 11.53b)
Debt / EBITDA = 6.50 (Net Debt 12.66b / EBITDA 2.01b)
Debt / FCF = 12.17 (Debt 13.06b / FCF TTM 1.07b)
Total Stockholder Equity = 10.88b (last 4 quarters mean)
RoA = 0.72% (Net Income 191.2m, Total Assets 26.47b )
RoE = 1.76% (Net Income TTM 191.2m / Total Stockholder Equity 10.88b)
RoCE = 3.30% (Ebit 790.4m / (Equity 10.88b + L.T.Debt 13.06b))
RoIC = 3.13% (Ebit 790.4m / (Assets 26.47b - Current Assets 1.21b))
WACC = unknown (E(31.56b)/V(44.62b) * Re(9.58%)) + (D(13.06b)/V(44.62b) * Rd(1.15%) * (1-Tc(none)))
Shares Correlation 3-Years: 87.88 | Cagr: 1.06%
Discount Rate = 9.58% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 74.46% ; FCFE base≈992.6m ; Y1≈1.09b ; Y5≈1.41b
Fair Price DCF = 41.19 (DCF Value 18.72b / Shares Outstanding 454.5m; 5y FCF grow 11.63% → 3.0% )
EPS Correlation: 42.68 | EPS CAGR: 309.9% | SUE: 0.07 | # QB: 0
Revenue Correlation: 98.51 | Revenue CAGR: 12.12% | SUE: 3.02 | # QB: 2

Additional Sources for VTR Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle